Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Eliquis 2.5 mg film-coated tablets

Active Ingredient:
apixaban
Company:  
Bristol-Myers Squibb-Pfizer See contact details
ATC code: 
B01AF02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Product Information Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

UK Eliquis (apixaban) Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

This risk minimisation material is a condition of the marketing authorisation. Please ensure that you are familiar with this material before prescribing Eliquis as it contains important safety information on the important risks of bleeding, and medication errors during treatment with apixaban and their appropriate management.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Bristol-Myers Squibb-Pfizer
Company image
Address
Bristol-Myers Squibb, ARC Uxbridge, Sanderson Road, New Denham, Denham, Buckinghamshire, UB8 1DH, UK
Telephone
+44 (0)1895 523 000
Medical Information Direct Line
+44 (0)800 731 1736
Medical Information e-mail
[email protected]